Head of mRNA Platform

Head of mRNA Platform

Business Introduction
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together.
Find out more:
Our approach to R&D


Position Summary

The Head of mRNA Platform will have a cross functional role as a single contributor or leading a small team. He/she is expected to work cross functionally with the Heads of Biochemistry, Chemistry and Data science, within Discovery tech, as well as with teams across GSK R&D, including VIDRU, TRD, and Research Tech.  

The Head of mRNA Platform will provide transformative leadership within GSK’s matrix organisation, driving the discovery, development, and maturation of mRNA platforms. This leader will play a pivotal role in advancing innovative mRNA technologies and ensuring their seamless transition from research to Technical Research and Development (TRD, MDS) for broader application. By leveraging cross-functional collaboration, state-of-the-art science, and strategic alignment, this role will elevate GSK’s capabilities in mRNA vaccine development to address evolving public health needs and emerging opportunities in both infectious and non-infectious diseases. 

mRNA vaccines are central to rapid responses to pathogen evolution, epidemiological shifts, and outbreak/pandemic scenarios, including influenza and COVID-19 strain adaptations. This role will focus on building and optimising robust mRNA platforms capable of delivering high-quality, scalable solutions for these challenges. Additionally, the Head of mRNA Platform will define and drive the strategic innovation roadmap for discovery platforms, balancing project delivery with forward-looking scientific opportunities to ensure GSK remains at the forefront of vaccine discovery. 

This new role prioritises a streamlined approach to platform development that integrates deeply within the matrix organisation. By focusing on platform maturation, innovation, and transition, the Head of mRNA Platform will drive GSK’s ability to respond nimbly to public health needs and position RNA as core element of the company’s vaccine innovation strategy.

Responsibilities

• Project First: Collaborate with Discovery Units to develop and optimise lead RNA vaccine candidates by providing transversal and enhanced capabilities, ensuring agile and efficient project delivery. 
• Tech Enabled: Drive end-to-end innovation for GSK’s Infectious Disease cutting-edge technology platforms within a 2-year timeframe to accelerate discovery and platform maturation. 
• Expert Led: Improve key interfaces across the R&D organisation by leveraging synergies, fostering collaboration, and boosting scientific innovation across functions. 

Additional Responsibilities 

• Define and execute a strategy for mRNA vaccine platform development, emphasising innovation, scalability, and readiness for TRD integration. 

• Develop and implement an innovation roadmap that balances immediate project needs with long-term scientific opportunities. 

• Invest in modular vaccine platforms (e.g., mRNA, protein subunits, adjuvants) designed for speed, flexibility, and manufacturability to minimise late-stage disruptions. 

• Apply platform-based approaches to enable “plug and play” of new antigens, reducing early development timelines. 

• Implement standardised CMC (Chemistry, Manufacturing, and Controls) approaches to compress timelines and streamline regulatory submissions. 

• Build and maintain strong external collaborations with world-class scientists and institutions to introduce cutting-edge technologies and ideas. 

• Lead cross-functional relationships across Vaccines R&D, TRD, and other groups, including Scientific Areas, Clinical Science, Toxicology, Data Science, Structural Biology, Translational Medicine, Regulatory Affairs, Business Development, and Global Patents. 

• Ensure delivery of high-quality data packages for regulatory filings, patents, and publications, integrating state-of-the-art science